Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.
Registration date period
Results ordered by trial registration date, descending.
  1. A Clinical Safety Study of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo Etude portant sur la tolérance clinique de sujets ayant été exposés aux vaccins candidats contre le virus Ebola Ad26.ZEBOV et/ou MVA-mBN226B

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    • To collect serious adverse event information from subjects exposed to Ad26.ZEBOV and/or MVA-BN-Filo in a Phase 1, 2, or 3 clinical study, for a total of 60 months after prime vaccination (including...

    Conditions:
    • Ebola
    Interventions:
    • Ad26.ZEBOV
    • MVA-BN-Filo
  2. AMIKINHAL (AMIKACIN inhaled)

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To prove that after the third day of invasive mechanical ventilation a three-day course of inhaled amikacin reduces the incidence of subsequent VAP

    Conditions:
    • Patient with mechanical ventilation through an endotracheal tube
    Interventions:
    • Amikacin
  3. A study to compare antibiotics used to treat children with severe acute malnutrition

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ISRCTN

    Background and study aims Children with severe malnutrition who are admitted to hospitals have a high mortality (death rate), usually due to infection. All children with severe malnutrition admitted...

    Conditions:
    • Invasive bacterial infection, Severe acute malnutrition
    Interventions:
    • CEFTRIAXONE
    • Benzyl penicillin
    • gentamicin and metronidazole
  4. This trial will test the drug filgotinib for the treatment of fistulas around the anus (perianal) as a complication of Crohn’s disease. Este ensayo probará el fármaco filgotinib para el tratamiento de fístulas alrededor del ano (perianal) como una complicación de la enfermedad de Crohn

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    The primary objective of this study is to evaluate the efficacy of filgotinib as compared to placebo in establishing combined fistula response at Week 24 Evaluar la eficacia de filgotinib en...

    Conditions:
    • Perianal Fistulizing Crohn’s Disease
    • enfermedad de Crohn perianal fistulizante
    Interventions:
    • Filgotinib
  5. Effect on weight loss of a diet inspired by traditional nutrition

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims A diet which avoids processed foods, such as the Paleolithic diet, can result in weight loss but seems impossible in modern times where refined food is dominant. The aim of...

    Conditions:
    • Obesity, diabetes
    Interventions:

    Unknown

  6. Design and validation of a fasting mimicking diet

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ISRCTN

    Background and study aims Critical illness is a state in which patients depend on drugs or machines to support or replace organ function to keep them alive and allow them to heal. Such patients are...

    Conditions:
    • Prolonged critical illness
    Interventions:

    Unknown

  7. Mechanical debulking to eliminate thrombolysis and/or open surgery from initial therapy of acute and subacute ischaemia of lower limbs

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims Peripheral arterial disease (PAD) is a common condition in which the blood flow to the legs is restricted. This happens because of the buildup of a fatty substance (plaque)...

    Conditions:
    • Acute and subacute ischeamia of lower limbs
    Interventions:

    Unknown